Literature DB >> 10996118

From katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia.

P Jordan1.   

Abstract

Treatment of schistosomiasis is now simple and control protects millions in Brazil, China and Egypt and many thousands in other countries. It is difficult, therefore, to visualise the frustration and despair of scientists and clinicians in Africa, and in Egypt in particular, at the beginning of the century faced with a disease described as 'perhaps the most dreadful of the remaining plagues of Egypt' (Madden, P.C., 1910). It was known to be caused by a trematode worm (discovered by Bilharz in 1852), but apparently with a life-cycle atypical of other parasites of that class in that the worms are unisexual and that no intermediate host had been identified. The cause of the disease was known but there was no treatment, and the question 'How are people infected?' remained unanswered. Rational preventive and control measures would be possible only when this question was answered. Investigations to answer it, and early attempts at control, constitute the basis of the following historical review. The controversies, theories and fertile imaginations of the eminent scientists, that preceded the unravelling of the schistosome life-cycle, are discussed and observations, techniques and ideas of the early researchers that were forgotten only to be rediscovered many years later, are highlighted.

Entities:  

Mesh:

Year:  2000        PMID: 10996118     DOI: 10.1016/s0001-706x(00)00121-2

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  24 in total

Review 1.  Milestones along the road of infection prevention in Egypt.

Authors:  H A El-Mahallawy; L M Mohsen; M Wassef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-01       Impact factor: 3.267

2.  When history was made in Khartoum Civil Hospital: First introduction of chemotherapy for schistosomiasis.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2015

Review 3.  To Reduce the Global Burden of Human Schistosomiasis, Use 'Old Fashioned' Snail Control.

Authors:  Susanne H Sokolow; Chelsea L Wood; Isabel J Jones; Kevin D Lafferty; Armand M Kuris; Michael H Hsieh; Giulio A De Leo
Journal:  Trends Parasitol       Date:  2017-11-07

4.  [Chronic hepatitis B with an unexpected coinfection].

Authors:  Thomas Göbel; Andreas Erhardt; Joachim Richter; Christopher Poremba; Dieter Häussinger
Journal:  Med Klin (Munich)       Date:  2010-12-07

5.  Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.

Authors:  Laure Johann; Didier Belorgey; Hsin-Hung Huang; Latasha Day; Matthieu Chessé; Katja Becker; David L Williams; Elisabeth Davioud-Charvet
Journal:  FEBS J       Date:  2015-08-03       Impact factor: 5.542

6.  Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.

Authors:  J Utzinger; G Raso; S Brooker; D De Savigny; M Tanner; N Ornbjerg; B H Singer; E K N'goran
Journal:  Parasitology       Date:  2009-11       Impact factor: 3.234

7.  Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis.

Authors:  C Lochmatter; C L Schneider; K Ingram; J Keiser; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

8.  Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children.

Authors:  Jana Kovač; Isabel Meister; Anna Neodo; Gordana Panic; Jean T Coulibaly; Christine Falcoz; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 9.  Maternal schistosomiasis: a growing concern in sub-Saharan Africa.

Authors:  Oyetunde T Salawu; Alexander B Odaibo
Journal:  Pathog Glob Health       Date:  2014-09-16       Impact factor: 2.894

10.  On the trail of a tropical disease.

Authors:  Alejandro Sánchez Alvarado
Journal:  Elife       Date:  2013-07-30       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.